Cargando…

Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial(1)(2)

Background: Food-based dietary patterns emphasizing plant protein that were evaluated in the Dietary Approaches to Stop Hypertension (DASH) and OmniHeart trials are recommended for the treatment of metabolic syndrome (MetS). However, the contribution of plant protein to total protein in these diets...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Alison M, Harris Jackson, Kristina A, Roussell, Michael A, West, Sheila G, Kris-Etherton, Penny M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Nutrition 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588738/
https://www.ncbi.nlm.nih.gov/pubmed/26354540
http://dx.doi.org/10.3945/ajcn.114.104026
_version_ 1782392681519906816
author Hill, Alison M
Harris Jackson, Kristina A
Roussell, Michael A
West, Sheila G
Kris-Etherton, Penny M
author_facet Hill, Alison M
Harris Jackson, Kristina A
Roussell, Michael A
West, Sheila G
Kris-Etherton, Penny M
author_sort Hill, Alison M
collection PubMed
description Background: Food-based dietary patterns emphasizing plant protein that were evaluated in the Dietary Approaches to Stop Hypertension (DASH) and OmniHeart trials are recommended for the treatment of metabolic syndrome (MetS). However, the contribution of plant protein to total protein in these diets is proportionally less than that of animal protein. Objective: This study compared 3 diets varying in type (animal compared with plant) and amount of protein on MetS criteria. Design: Sixty-two overweight adults with MetS consumed a healthy American diet for 2 wk before being randomly allocated to either a modified DASH diet rich in plant protein (18% protein, two-thirds plant sources, n = 9 males, 12 females), a modified DASH diet rich in animal protein (Beef in an Optimal Lean Diet: 18.4% protein, two-thirds animal sources, n = 9 males, 11 females), or a moderate-protein diet (Beef in an Optimal Lean Diet Plus Protein: 27% protein, two-thirds animal sources, n = 10 males, 11 females). Diets were compared across 3 phases of energy balance: 5 wk of controlled (all foods provided) weight maintenance (WM), 6 wk of controlled weight loss (minimum 500-kcal/d deficit) including exercise (WL), and 12 wk of prescribed, free-living weight loss (FL). The primary endpoint was change in MetS criteria. Results: All groups achieved ∼5% weight loss at the end of the WL phase and maintained it through FL, with no between-diet differences (WM compared with WL, FL, P < 0.0001; between diets, P = NS). All MetS criteria decreased independent of diet composition (main effect of phase, P < 0.01; between diets, P = NS). After WM, all groups had a MetS prevalence of 80–90% [healthy American diet (HAD) compared with WM, P = NS], which decreased to 50–60% after WL and was maintained through FL (HAD, WM vs WL, FL, P < 0.01). Conclusions: Weight loss was the primary modifier of MetS resolution in our study population regardless of protein source or amount. Our findings demonstrate that heart-healthy weight-loss dietary patterns that emphasize either animal or plant protein improve MetS criteria similarly. This study was registered at clinicaltrials.gov as NCT00937638.
format Online
Article
Text
id pubmed-4588738
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American Society for Nutrition
record_format MEDLINE/PubMed
spelling pubmed-45887382015-10-21 Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial(1)(2) Hill, Alison M Harris Jackson, Kristina A Roussell, Michael A West, Sheila G Kris-Etherton, Penny M Am J Clin Nutr Cardiovascular Disease Risk Background: Food-based dietary patterns emphasizing plant protein that were evaluated in the Dietary Approaches to Stop Hypertension (DASH) and OmniHeart trials are recommended for the treatment of metabolic syndrome (MetS). However, the contribution of plant protein to total protein in these diets is proportionally less than that of animal protein. Objective: This study compared 3 diets varying in type (animal compared with plant) and amount of protein on MetS criteria. Design: Sixty-two overweight adults with MetS consumed a healthy American diet for 2 wk before being randomly allocated to either a modified DASH diet rich in plant protein (18% protein, two-thirds plant sources, n = 9 males, 12 females), a modified DASH diet rich in animal protein (Beef in an Optimal Lean Diet: 18.4% protein, two-thirds animal sources, n = 9 males, 11 females), or a moderate-protein diet (Beef in an Optimal Lean Diet Plus Protein: 27% protein, two-thirds animal sources, n = 10 males, 11 females). Diets were compared across 3 phases of energy balance: 5 wk of controlled (all foods provided) weight maintenance (WM), 6 wk of controlled weight loss (minimum 500-kcal/d deficit) including exercise (WL), and 12 wk of prescribed, free-living weight loss (FL). The primary endpoint was change in MetS criteria. Results: All groups achieved ∼5% weight loss at the end of the WL phase and maintained it through FL, with no between-diet differences (WM compared with WL, FL, P < 0.0001; between diets, P = NS). All MetS criteria decreased independent of diet composition (main effect of phase, P < 0.01; between diets, P = NS). After WM, all groups had a MetS prevalence of 80–90% [healthy American diet (HAD) compared with WM, P = NS], which decreased to 50–60% after WL and was maintained through FL (HAD, WM vs WL, FL, P < 0.01). Conclusions: Weight loss was the primary modifier of MetS resolution in our study population regardless of protein source or amount. Our findings demonstrate that heart-healthy weight-loss dietary patterns that emphasize either animal or plant protein improve MetS criteria similarly. This study was registered at clinicaltrials.gov as NCT00937638. American Society for Nutrition 2015-10 2015-09-09 /pmc/articles/PMC4588738/ /pubmed/26354540 http://dx.doi.org/10.3945/ajcn.114.104026 Text en © 2015 American Society for Nutrition This is a free access article, distributed under terms (http://www.nutrition.org/publications/guidelines-and-policies/license/) that permit unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cardiovascular Disease Risk
Hill, Alison M
Harris Jackson, Kristina A
Roussell, Michael A
West, Sheila G
Kris-Etherton, Penny M
Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial(1)(2)
title Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial(1)(2)
title_full Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial(1)(2)
title_fullStr Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial(1)(2)
title_full_unstemmed Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial(1)(2)
title_short Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial(1)(2)
title_sort type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial(1)(2)
topic Cardiovascular Disease Risk
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588738/
https://www.ncbi.nlm.nih.gov/pubmed/26354540
http://dx.doi.org/10.3945/ajcn.114.104026
work_keys_str_mv AT hillalisonm typeandamountofdietaryproteininthetreatmentofmetabolicsyndromearandomizedcontrolledtrial12
AT harrisjacksonkristinaa typeandamountofdietaryproteininthetreatmentofmetabolicsyndromearandomizedcontrolledtrial12
AT roussellmichaela typeandamountofdietaryproteininthetreatmentofmetabolicsyndromearandomizedcontrolledtrial12
AT westsheilag typeandamountofdietaryproteininthetreatmentofmetabolicsyndromearandomizedcontrolledtrial12
AT krisethertonpennym typeandamountofdietaryproteininthetreatmentofmetabolicsyndromearandomizedcontrolledtrial12